Breast Lift (Mastopexy) | Additional planning and revision decisions

The ideal nipple position is usually between half and two-thirds of the distance down the ideal breast mound, measured from the upper breast border; in many C–D cup patients this is about 10 cm below that border. The upper breast border is where breast meets chest wall. Two patients can have the same glandular ptosis, yet one has nipple ptosis and the other does not, so nipple height alone does not define droop. Pseudoptosis is bottoming out of the inframammary fold, and breast ptosis should be judged against the upper breast border rather than the fold. This distinction matters because nipple ptosis is relatively simpler to correct, whereas glandular ptosis and pseudoptosis need different surgical judgment.

A breast lift removes excess skin and reshapes tissue to raise the breast and move the nipple to a better position. An implant mainly adds volume and projection; by itself it does not significantly change vertical nipple position. In a cadaveric study, nipple movement related to projection and pocket factors, not a reliable lift. Implants may not fill the upper pole as expected, and if an implant descends into the lower pole, fullness there can look worse. Mastopexy is indicated for moderate or severe ptosis, while augmentation alone may not elevate the nipple. Capsular contracture can also alter breast shape. Dr. Vishal Purohit can discuss these limits during consultation.

The decision depends on the clinical scenario, surgeon experience and patient choice, not only risk. Mild to moderate ptosis under about 4 cm elevation is favorable for single-stage augmentation mastopexy; severe ptosis over 4 cm may be considered for two stages. Women with high risk for wound-healing complications, such as diabetes, tobacco use or immunocompromise, are not good candidates for combined surgery. If staged, many surgeons perform mastopexy first, then augmentation no earlier than three months later, allowing tissue-related revisions. One-stage surgery avoids a second operation but requires conservative implant choice, skin resection and undermining. Clear patient expectations and careful selection matter.

The available evidence concerns repeat breast reduction rather than mastopexy after reduction. In repeat reduction, once a pedicle is created, a significant blood supply to the nipple-areola complex has been transsected, so the dominant supply may remain through the original pedicle. New vessel growth may not be enough if that pedicle is later transsected and a different one is fashioned. Risks are greater with a longer pedicle and factors such as smoking or obesity. If the previous pedicle is known, it should be used when possible. Therefore, a later lift after reduction needs careful assessment of nipple blood supply, scars and prior pedicle type before any surgical plan is finalized.

Breast lift surgery raises the breast by removing excess skin and tightening tissue, but moving the nipple too far can compromise its blood supply. If blood supply is insufficient, part or all of the nipple may die; sometimes a scab forms and heals underneath, and revision surgery may later be needed. In selected cases where the nipple must be moved a very long distance, free nipple grafting may be used because other techniques would leave the nipple at high risk of insufficient blood supply. The exact approach depends on breast size, shape, the size and position of your areolas, the degree of breast sagging, skin quality and elasticity, and the amount of extra skin.

Mastopexy reshapes and lifts a sagging breast by removing excess skin and tightening surrounding tissue. The appropriate technique depends on breast size and shape, areola position, degree of sagging, and skin quality and elasticity. It does not significantly change breast size or round out the upper breast; augmentation or reduction may be combined when needed. Asymmetry correction is rarely perfect because different breasts with different surgeries can have different outcomes at different times, and staged correction may be needed. Long-term shape can also change with tissue atrophy, weight change, pregnancy or lactation after surgery. All patients should be warned about the possibility of a subsequent revision.

After mastopexy, the nipple-areola complex depends on its blood supply. If it becomes congested or ischemic, the colour may change; darker skin can make this harder to detect. A hematoma can also compromise flow. Postoperative monitoring matters, and signs of compromise may be addressed with suture release and possible return to theatre. Not every colour change means tissue loss, but blue or persistent darkening should not be watched at home. Ischemia can be difficult to detect in some skin pigmentations, particularly darker complexions, so any new blue, purple or persistent dark colour should prompt urgent in-person assessment. If bleeding is assessed, rapid return of non-congested bright blood is reassuring, while poor flow may need urgent surgical review.

After breast augmentation, reduction or mastopexy, most women need the same follow-up, examination and mammogram screening as women without prior breast surgery. Minor lumps may be due to suture granulomas, internal scars or fat necrosis, and these tend to improve as healing resolves. Rarely, inclusion cysts or small abscesses may present years after surgery. Any suspicious mass after the normal healing period should be evaluated as any other breast lump. After breast reduction, a baseline mammogram one year later may show benign calcifications from fat necrosis. Women with breast implants should follow routine mammogram screening guidelines, with appropriate Eklund views at experienced centers.

A breast lift raises the breast by removing excess skin and tightening surrounding tissue. Recurrent lower-pole stretch is often linked to inadequate lower-pole debulking, underresection of lower-pole vertical excess skin, or oversized implants stretching the lower pole over time. Correction may focus on reducing those forces rather than adding volume; in an isolated lower-pole stretch, the nipple-areola complex may not need repositioning. Evaluating root causes helps reduce repeat lower-pole failure, and large implants may stretch and weigh down tissue, counteracting the lift. During revision, special attention to debulking the lower pole helps minimize recurrent failure, and the plan is individualized with your surgeon.

Mastopexy removes tissue and skin, which can change fibroglandular tissue distribution. On mammography, this may appear as architectural distortion, parenchymal scarring, focal asymmetries, fat necrosis, upward-sweeping distortion, fibrotic bands, or calcification around the nipple-areolar complex from permanent suture in many women. More recent evidence does not support unique screening protocols after breast reduction or mastopexy. Average-risk women under 40 may have harms outweighing benefits, while increased-risk patients should follow NCCN and ACR guidance. For women 40 or older, preoperative mammography is recommended. Some investigators suggest a postoperative mammogram within the year after surgery, but comparisons found no significant difference in identified abnormalities, and postoperative screening did not increase interventions compared with controls.